News

A STRESSED mum has shared how she hypnotised herself into shedding nearly two stone, getting over her paralysing fear of the ...
Pointing to Ozempic as a paradigm shift, an elite rehab center is experimenting with GLP-1s to tame many forms of addiction.
Presented by AstraZeneca{beacon} Health Care Health Care   The Big Story CMS targets hospitals with site-neutral drug ruleThe ...
There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still ...
Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...
A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists ...
Wegovy has taken the weight loss world by storm—and it's not just hype. People are finally seeing real results, and it’s changing the game for those who’ve struggled with weight for years. Unlike ...
A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence individuals' weight loss after taking GLP-1RAs such as semaglutide (sold under the brand names ...
These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and why.
Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure increasing danger of macular degeneration.
More people are "microdosing" GLP-1 medications like Ozempic, Wegovy, and Mounjaro. Here's what to know and what to be cautious of, according to doctors.
People using GLP-1 drugs like Ozempic are reporting "Ozempic teeth," an unusual side effect impacting dental health. "Ozempic teeth" may involve tooth decay, sensitivity, and tooth loss. Dentists ...